van Dijck J, Verbeek A, Hendriks J, Holland R, Mravunac M
Department of Epidemiology, University of Nijmegen, The Netherlands.
Br J Cancer. 1996 Dec;74(11):1838-42. doi: 10.1038/bjc.1996.640.
We studied outcomes of mammographic screening in women older than 65 years. In 1975, breast cancer screening was started in Nijmegen, The Netherlands, for women aged 35-65 years. Since 1977, approximately 7700 older women have also been invited for biennial one-view mammography. This report is based on ten screening rounds from 1975 to 1994. The results of the subsequent screening rounds in the age groups 65-69 years, 70-74 years and 75 years and older were: participation rates 55%, 39% and 15%; screen-detected cancer rates 5.6%, 6.9% and 7.8%; interval cancer rates 2.0%, 1.8%, and 3.5%; and predictive values of referral 62%, 64% and 62% respectively. In all age groups, screen-detected patients had smaller tumours and a lower prevalence of axillary lymph node involvement than unscreened patients. Our conclusion is that, in women aged 65 years, and older, breast cancer can be detected at an earlier stage by mammographic screening.
我们研究了65岁及以上女性的乳腺钼靶筛查结果。1975年,荷兰奈梅亨开始对35至65岁的女性进行乳腺癌筛查。自1977年以来,约7700名老年女性也被邀请每两年进行一次单视角乳腺钼靶检查。本报告基于1975年至1994年的十轮筛查。65至69岁、70至74岁以及75岁及以上年龄组后续筛查轮次的结果如下:参与率分别为55%、39%和15%;筛查发现癌症的比率分别为5.6%、6.9%和7.8%;间期癌症发生率分别为2.0%、1.8%和3.5%;转诊的预测值分别为62%、64%和62%。在所有年龄组中,与未接受筛查的患者相比,筛查发现的患者肿瘤更小,腋窝淋巴结受累的患病率更低。我们的结论是,对于65岁及以上的女性,通过乳腺钼靶筛查可以在更早阶段发现乳腺癌。